Jane Street Group, LLC Apellis Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 19,280 shares of APLS stock, worth $506,485. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,280

Previous 200,889 90.4%

Holding current value

$506,485

Previous $7.71 Million 92.78%

% of portfolio

0.0%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$28.84 - $41.15 $5.24 Million - $7.47 Million	-181,609 Reduced 90.4%	19,280 $556,000
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $2.74 Million - $4.29 Million	71,880 Added 55.72%	200,889 $7.71 Million
Q1 2024 May 15, 2024	SELL	$55.39 - $72.47 $16.9 Million - $22.2 Million	-305,692 Reduced 70.32%	129,009 $7.58 Million
Q4 2023 Feb 14, 2024	BUY	$37.14 - $64.82 $6 Million - $10.5 Million	161,475 Added 59.1%	434,701 $26 Million
Q3 2023 Nov 14, 2023	SELL	$23.65 - $89.22 $4.92 Million - $18.5 Million	-207,856 Reduced 43.21%	273,226 $10.4 Million
Q2 2023 Aug 14, 2023	BUY	$76.68 - $93.31 $32 Million - $39 Million	417,698 Added 659.0%	481,082 $43.8 Million
Q1 2023 May 15, 2023	BUY	$46.59 - $66.96 $2.3 Million - $3.31 Million	49,363 Added 352.06%	63,384 $4.18 Million
Q4 2022 Feb 14, 2023	SELL	$43.24 - $61.04 $128,725 - $181,716	-2,977 Reduced 17.51%	14,021 $725,000
Q3 2022 Nov 14, 2022	SELL	$44.76 - $69.66 $3.47 Million - $5.4 Million	-77,584 Reduced 82.03%	16,998 $1.16 Million
Q2 2022 Aug 16, 2022	BUY	$35.07 - $59.21 $682,883 - $1.15 Million	19,472 Added 25.92%	94,582 $4.28 Million
Q1 2022 May 17, 2022	SELL	$35.46 - $54.12 $907,811 - $1.39 Million	-25,601 Reduced 25.42%	75,110 $3.82 Million
Q4 2021 Feb 15, 2022	BUY	$30.74 - $49.16 $2.61 Million - $4.17 Million	84,768 Added 531.69%	100,711 $4.76 Million
Q3 2021 Nov 16, 2021	SELL	$31.4 - $69.84 $584,636 - $1.3 Million	-18,619 Reduced 53.87%	15,943 $525,000
Q2 2021 Aug 16, 2021	BUY	$40.9 - $64.9 $468,877 - $744,013	11,464 Added 49.63%	34,562 $2.18 Million
Q1 2021 May 18, 2021	SELL	$40.8 - $57.39 $1.38 Million - $1.94 Million	-33,854 Reduced 59.44%	23,098 $991,000
Q4 2020 Feb 17, 2021	BUY	$30.79 - $57.2 $442,821 - $822,650	14,382 Added 33.78%	56,952 $3.26 Million
Q3 2020 Nov 17, 2020	BUY	$25.89 - $33.65 $507,210 - $659,237	19,591 Added 85.26%	42,570 $1.28 Million
Q2 2020 Aug 17, 2020	BUY	$24.8 - $38.49 $569,879 - $884,461	22,979 New	22,979 $750,000
Q1 2020 May 15, 2020	SELL	$17.91 - $44.33 $145,697 - $360,624	-8,135 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$22.1 - $30.8 $1.94 Million - $2.7 Million	-87,589 Reduced 91.5%	8,135 $249,000
Q3 2019 Nov 14, 2019	BUY	$24.09 - $32.18 $1.98 Million - $2.65 Million	82,285 Added 612.29%	95,724 $2.31 Million
Q2 2019 Aug 15, 2019	BUY	$18.0 - $25.34 $241,902 - $340,544	13,439 New	13,439 $341,000

Others Institutions Holding APLS

# of Institutions

308

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.89B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Apellis Pharmaceuticals, Inc. Transaction History